Form 4: Aethlon Medical Director Forfeits Shares for Tax
Statement of Changes in Beneficial Ownership (Form 4)
Aethlon Medical Director Nicolas Gikakis forfeited 179 shares of common stock to cover tax withholdings related to restricted stock unit conversion.
Summary
- Director Nicolas Gikakis of Aethlon Medical Inc. (AEMD) forfeited 179 shares of common stock.
- The forfeiture occurred on December 31, 2025, at a price of $2.77 per share.
- This transaction was to cover tax withholdings upon the conversion of 268 vested and outstanding restricted stock units into common stock.
- Following the transaction, Gikakis beneficially owns 2,357 shares of common stock directly.
- The restricted stock units were part of a grant previously reported on April 25, 2025.
Sentiment
Score: 5
Explanation: Neutral. This is a routine, non-discretionary transaction for tax purposes related to equity compensation, which has no direct bearing on the company's operational performance or future prospects.
Future Outlook
NA
Industry Context
This is a routine insider transaction related to compensation and tax obligations, common across all industries for executives and directors receiving equity compensation. It does not reflect specific industry trends for Aethlon Medical.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine, non-discretionary transaction for tax purposes related to director compensation.
- No direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 04/25/2025 | Date of original Form 4 filing reporting the grant of restricted stock units. |
| 12/31/2025 | Transaction date for the forfeiture of common stock. |
| 01/02/2026 | Date of filing of this Form 4. |
Keywords
Aethlon Medical, AEMD, Nicolas Gikakis, Form 4, Insider Transaction, Stock Forfeiture, Restricted Stock Units, Tax Withholding, Director Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.